Glutathione, often referred to as the "master antioxidant," is a tripeptide composed of three amino acids: cysteine, glutamate, and glycine
Peptide or compound Primary category What researchers study Status context Semaglutide GLP-1 / metabolic Appetite, glucose, and cardiometabolic signaling FDA-approved products exist for specific indications Tirzepatide GIP/GLP-1 / metabolic Appetite, glucose, and metabolic signaling FDA-approved products exist for specific indications Retatrutide Triple agonist / metabolic GLP-1, GIP, and glucagon receptor signaling Investigational BPC-157 Tissue-repair research Gastrointestinal, tendon, and angiogenesis pathways Research-only
Emerging therapies targeting bilirubin pathways Recent advancements in molecular and pharmacological research have introduced novel therapeutic strategies for modulating bilirubin metabolism, offering potential clinical applications in hepatobiliary disorders
Limitations: One rabbit study
Inhibitors of GH signal transduction pathways (post-receptor) Given that GH activates JAK-STAT, PI3K/AKT/mTOR and MAPK signaling, agents which target components of these signaling pathways would be expected to modulate pathway-specific GH effects
